Clinical Outcome Measures for Multiple Sclerosis
- 1 January 1996
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisAnnals of Neurology, 1995
- Design strategies in multiple sclerosis clinical trialsAnnals of Neurology, 1994
- The extended disability status scale (EDSS) as a predictor of impairments of functional activities of daily living in multiple sclerosisJournal of the Neurological Sciences, 1993
- Inter‐ and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS)Neurology, 1992
- Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaquesAnnals of Neurology, 1992
- An Assessment of Disability Rating Scales Used in Multiple SclerosisArchives of Neurology, 1991
- The efficacy of azathioprine in relapsing ‐ remitting multiple sclerosisNeurology, 1991
- Interrater Reliability in Assessing Functional Systems and Disability on the Kurtzke Scale in Multiple SclerosisArchives of Neurology, 1988
- EFFECT OF TOTAL LYMPHOID IRRADIATION IN CHRONIC PROGRESSIVE MULTIPLE SCLEROSISThe Lancet, 1986
- NEW CONCEPT OF CRITICAL STEPS IN COURSE OF CHRONIC DEBILITATING NEUROLOGIC DISEASE IN EVALUATION OF THERAPEUTIC RESPONSEA.M.A. Archives of Neurology & Psychiatry, 1951